Clearmind Medicine Accounts Payable

Clearmind Medicine (CMND) currently reports a accounts payable of $710K as of April 2026. That compares with $480K in the prior-year period — up 50.1% year over year. Use the charts on this page to explore Clearmind Medicine's accounts payable history and peer comparisons.

Clearmind Medicine's accounts payable increased from $480K to $710K — a 50.1% year-over-year increase (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clearmind Medicine reported $710K in accounts payable as of April 2026. That compares with $480K in the prior-year period — up 50.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $710K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clearmind Medicine, and consider following CMND for alerts when major investors trade the stock.

Clearmind Medicine is classified in the Healthcare sector. On accounts payable, it currently shows $710K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMND with unrelated industries.